Inc Ransom claims data breach against omegabiotek.com

• Ransomware group: Inc Ransom
• Country: United States
• Sector: Technology
• Announcement date: September 4, 2025

Inc Ransom lists omegabiotek.com on leak site

The threat actor known as Inc Ransom has listed omegabiotek.com on its leak portal, alleging a data breach. According to the announcement, the group claims to have compromised 38.3 GB of data belonging to the organization. This listing appeared in August 2025, and the group appears to be employing double-extortion tactics to exert pressure on the victim.

Details of the alleged breach

The announcement specifies a total size of 38.3 GB, but no detailed breakdown of the file types is provided. The threat actor's post indicates that the data was allegedly exfiltrated around August 1, 2025, though the official announcement on the leak site was made on September 4, 2025. No specific ransom demand has been disclosed by the group in the current listing.

While the group has not provided a detailed breakdown of the file types, the nature of the organization suggests potential risks. Given the company's focus on nucleic acid isolation products, the stolen data may contain trade secrets or employee information.

About Omega Bio-tek

Omega Bio-tek is a company that develops and manufactures nucleic acid isolation products for clinical research, biotechnology, and agricultural applications. Founded in 1998, the firm offers over 900 products, including magnetic beads and silica membranes, for both manual and automated processing.

Analysis and industry implications

This incident reflects the Inc Ransom group's tendency to target organizations using double-extortion strategies. In a double-extortion scenario, attackers not only encrypt an organization's systems but also steal sensitive data, threatening to leak it publicly if a ransom is not paid. This method increases the pressure on victims by threatening their reputation and legal standing.

The alleged data exposure may compromise the organization's intellectual property and operational continuity. As the organization is based in the United States, a potential data breach could trigger legal proceedings under state-level privacy laws and sectoral regulations. Furthermore, the exposure of employee and customer information may lead to secondary risks such as targeted phishing attacks and identity theft.

Given that the organization is an ISO 9001:2015 certified biotechnology firm, the breach may also have negative implications for supply chain security. In the biotechnology sector, maintaining the integrity of research and manufacturing processes is critical. Organizations in this sector can take several defensive steps to mitigate such risks, including implementing robust data encryption, enforcing strict access controls, and conducting regular security audits to protect intellectual property and sensitive research data.